Episode Details

Back to Episodes
Can Ferroptosis Supplements Protect Vision in Glaucoma? What the New Dnajb14 Discovery Really Means

Can Ferroptosis Supplements Protect Vision in Glaucoma? What the New Dnajb14 Discovery Really Means

Published 5 months, 2 weeks ago
Description

This audio article is from VisualFieldTest.com.

Read the full article here: https://visualfieldtest.com/en/can-ferroptosis-supplements-protect-vision-in-glaucoma-what-the-new-dnajb14-discovery-really-means

Test your visual field online: https://visualfieldtest.com

Support the show so new episodes keep coming: https://www.buzzsprout.com/2563091/support

Excerpt:

The Ferroptosis Hype in Glaucoma: Hope or Hype? Imagine reading about a magic pill that could stop glaucoma by blocking a new form of cell death called ferroptosis. Some reports even mention a recent gene finding (DNAJB14) that sounds like a cure-in-the-making. It’s a captivating idea – protect your vision with a supplement! But before you start popping supplements, let’s break it down. We’ll look at what the science actually says, what’s only been shown in lab animals, and what claims are likely misleading or risky. In the end, we’ll give you clear takeaways on what really can help your eyesight. What Is Ferroptosis, Anyway? Ferroptosis is not a household word, but it’s essentially a newly recognized way cells can die. Unlike typical cell death (like old cells dying normally), ferroptosis is driven by iron and oxidative stress. When tiny cell parts (like membranes) get overloaded with iron and reactive oxygen species (chemicals that cause damage), they literally rust themselves to death. In simple terms: imagine your cells corroding from the inside out. It’s been studied in basic science (cells in dishes and animals), and researchers think it might happen in eye diseases. In the context of glaucoma, the cells of concern are retinal ganglion cells (RGCs), the nerve cells in your eye that send visual signals to the brain. These cells die off in glaucoma, which causes gradual vision loss. Scientists have found signs of ferroptosis in animal models of glaucoma. For example, high eye pressure and other distress signals trigger iron release and oxidative stress, which then cause RGC death by ferroptosis (). In animal studies, blocking ferroptosis chemically (using experimental drugs like ferrostatin-1) can protect these neurons from dying (). These findings suggest the idea is biologically plausible – oxidative damage and iron overload do seem to be part of glaucoma-related cell death. Yet it’s crucial to note: most of this evidence is from lab experiments and animal models, not from people. The human eye is much more complex than an isolated cell or a mouse. So far, we lack clinical trials in humans proving ferroptosis inhibitors help glaucoma patients. In fact, in glaucoma patients doctors have observed higher levels of oxidative stress markers (like malondialdehyde, a sign of lipid peroxidation) and lower natural antioxidants (like glutathione) (). These observations are consistent with ferroptosis happening. But observation is not the same as proof that a supplement can stop it. Supplements and Claims: Separating Plausible from Pointless or Risky Because ferroptosis involves free radicals (oxidative stress) and iron, many people jump to the idea of taking antioxidants or iron binders as “ferroptosis supplements.” You may have seen products or advice suggesting things like melatonin, vitamin E, or herbal extracts to protect your eyes. Here’s what we know: Biologically plausible ideas: Antioxidants can neutralize free radicals, and indeed, some studies show antioxidant-like substances protect retinal cells in lab tests. For example, the hormone melatonin (also a mild antioxidant) protected retinal ganglion cells in mice under high eye pressure by blocking ferroptosis (). Similarly, N-acetylcysteine (NAC) can boost the cell’s own antioxidant glutathion

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us